Immunic Inc (NASDAQ:IMUX), a biotech company developing oral therapies for chronic inflammatory and autoimmune diseases, will participate in two upcoming events: BIO-Europe in Vienna, Austria (Nov. 3–5), with CEO Dr. Daniel Vitt and team joining partnering activities, and the Jefferies Global Healthcare Conference in London (Nov. 19–20), where Dr. Vitt and COO Jason Tardio will hold one-on-one investor meetings.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com